Obesity and resistance to insulin are closely associated with the development of low-grade inflammation. Interleukin 6 (IL-6) is linked to obesity-associated inflammation; however, its role in this context remains controversial. Here we found that mice with an inactivated gene encoding the IL-6R chain of the receptor for IL-6 in myeloid cells (Il6ra ∆myel mice) developed exaggerated deterioration of glucose homeostasis during diet-induced obesity, due to enhanced resistance to insulin. Tissues targeted by insulin showed increased inflammation and a shift in macrophage polarization. IL-6 induced expression of the receptor for IL-4 and augmented the response to IL-4 in macrophages in a cell-autonomous manner. Il6ra ∆myel mice were resistant to IL-4-mediated alternative polarization of macrophages and exhibited enhanced susceptibility to lipopolysaccharide (LPS)-induced endotoxemia. Our results identify signaling via IL-6 as an important determinant of the alternative activation of macrophages and assign an unexpected homeostatic role to IL-6 in limiting inflammation. npg
A r t i c l e s Western societies have experienced a lifestyle shift toward less physical activity and more consumption of energy-dense food; those changes have led to a substantial increase in overweight and obese people 1 . Obesity is associated with a chronic, low-grade inflammatory state, reflected by infiltration and activation of cells of the immune system in adipose tissue, as well as a systemically greater abundance of proinflammatory cytokines [2] [3] [4] . Those cytokines in turn activate intracellular stress-signaling cascades associated with the transcription factor NF-κB and the kinase Jnk, which subsequently inhibit the action of insulin in target tissues such as adipose tissue, liver, skeletal muscle and even the central nervous system [5] [6] [7] . Prolonged inhibition of insulin signaling eventually leads to the development of resistance to insulin and, ultimately, progression to overt type 2 diabetes mellitus 8, 9 .
Interleukin 6 (IL-6) is a cytokine linked to obesity and resistance to insulin; however, it is still unclear whether IL-6 serves a harmful role or a protective role in this context 10 . IL-6 increases in abundance in the circulation with the degree of obesity 11 , and acute infusion of IL-6 impairs sensitivity to insulin in mice 12 . However, deficiency in IL-6 leads to adult-onset obesity 13 , and hepatic disruption of IL-6 signaling causes resistance to insulin 14 .
Because macrophages are central mediators of obesityassociated inflammation, we aimed to directly investigate signaling by IL-6 in these cells. We found that IL-6 primed macrophages for IL-4-dependent M2 polarization by inducing expression of the receptor for IL-4 (IL-4R). In mice with conditional inactivation of the gene encoding the IL-6Rα chain of the receptor for IL-6 (Il6ra) in myeloid cells, we observed a greater propensity to develop obesity-induced inflammation and intolerance for glucose, as well as an exaggerated response to lipopolysaccharide (LPS)-induced endotoxemia. Our results identify IL-6 as a regulator of the alternative activation of macrophages during inflammatory conditions such as obesity and endotoxemia.
RESULTS

Signaling by IL-6 in myeloid cells regulates glucose homeostasis
To investigate the role of signaling by IL-6 in macrophages in obesity, we conditionally inactivated Il6ra in myeloid cells in mice. For this, we generated mice heterozygous for a transgene encoding Cre recombinase expressed via the gene encoding LysM (LysM-Cre), which is expressed specifically in cells of the myeloid lineage 15 , and homozygous for loxP-flanked Il6ra alleles (Il6ra fl/fl LysM-Cre Tg/wt ; A r t i c l e s called 'Il6ra ∆myel ' here). Il6ra fl/fl littermates without the LysM-Cre transgene served as controls. To verify efficient disruption of IL-6 signaling in these mice, we isolated bone marrow-derived macrophages (BMDMs) from Il6ra fl/fl and Il6ra ∆myel mice and stimulated them with IL-6. Immunoblot analysis revealed robust phosphorylation of STAT3 in BMDMs derived from Il6ra fl/fl mice (called 'control BMDMs' here) upon stimulation with IL-6, whereas phosphorylated STAT3 was undetectable in lysates of IL-6-stimulated BMDMs derived from Il6ra ∆myel mice (called 'Il6ra −/− BMDMs' here) ( Supplementary Fig. 1a ). Next we exposed Il6ra fl/fl and Il6ra ∆myel mice to either normal chow diet (NCD) or a high-fat diet (HFD) and monitored body weight from 4 weeks of age to 19 weeks of age. The HFD induced more weight gain than did the NCD; however, body weight was similar for Il6ra fl/fl mice and their Il6ra ∆myel counterparts for each diet (Fig. 1a) . In line with their unaltered development of obesity, Il6ra fl/fl and Il6ra ∆myel mice fed a NCD or HFD exhibited similar body composition, fat-pad weight and, as an indirect measure of body fat content, serum leptin concentrations ( Supplementary Fig. 1b-d) . Moreover, Il6ra ∆myel mice showed no difference in oxygen consumption or daily caloric intake compared with that of Il6ra fl/fl mice ( Supplementary Fig. 1e ,f). To analyze possible alterations in glucose homeostasis, we subjected Il6ra fl/fl and Il6ra ∆myel mice to glucose-tolerance tests. Whereas Il6ra fl/fl and Il6ra ∆myel mice fed a NCD had comparable blood glucose concentrations during the glucose-tolerance test ( Supplementary Fig. 2a ), Il6ra ∆myel mice fed a HFD were significantly more intolerant to glucose than were their Il6ra fl/fl counterparts (Fig. 1b) . Similarly, whereas mice fed a NCD showed no genotype-related difference in their response to an insulin-tolerance test ( Supplementary Fig. 2b ), Il6ra ∆myel mice fed a HFD were more resistant to insulin than were their Il6ra fl/fl counterparts ( Fig. 1c) . Moreover, the deterioration in glucose homeostasis in Il6ra ∆myel fed a HFD was also reflected by the higher fasting serum insulin concentrations and enhanced HOMA-IR indices ('homeostatic model assessment index of insulin resistance') in Il6ra ∆myel fed a HFD compared with that of their Il6ra fl/fl counterparts ( Fig. 1d,e ).
Insulin exerts its blood glucose-lowering effects by promoting the uptake of glucose in skeletal muscle and adipose tissue and through the suppression of de novo gluconeogenesis, predominantly in liver 16 .
To determine which of those processes was impaired in Il6ra ∆myel mice fed a HFD, we used euglycemic-hyperinsulinemic clamps. Il6ra ∆myel mice had a 50% lower glucose-infusion rate in the steady state ( Fig. 1f and Supplementary Fig. 2c,d) , which further supported the proposal that these mice developed a profound degree of resistance to insulin. Moreover, we assessed insulin-stimulated uptake of glucose in skeletal muscle, brown adipose tissue (BAT) and white adipose tissue (WAT). While we observed no difference between Il6ra fl/fl mice fed a HFD and their Il6ra ∆myel counterparts in terms of insulin-induced uptake of glucose in the skeletal muscle, insulinstimulated uptake of glucose was 25% lower in WAT and 40% lower in BAT of Il6ra ∆myel mice than in their Il6ra fl/fl counterparts ( Fig. 1g) . Moreover, the ability of insulin to suppress lipolysis and limit expression of the gene encoding hormone-sensitive lipase in WAT was significantly impaired in Il6ra ∆myel mice relative to its ability to do so in their Il6ra fl/fl counterparts ( Fig. 1h,i) ; this indicated resistance to insulin in the WAT and BAT of Il6ra ∆myel mice fed a HFD. Finally, insulin-mediated suppression of hepatic glucose production in Il6ra ∆myel mice fed a HFD was 50% that of their Il6ra fl/fl counterparts ( Fig. 1j) . Consistent with that finding, expression of the gene encoding glucose-6-phosphatase, a rate-limiting enzyme of 
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A r t i c l e s gluconeogenesis, was significantly higher in livers of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts during clamping and in the fasted state ( Fig. 1k and Supplementary Fig. 2e ). Furthermore, hepatic resistance to insulin was accompanied by a greater abundance of liver triglycerides and a higher concentration of triglycerides in serum of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts ( Supplementary Fig. 2f,g) . Thus, signaling by IL-6 in myeloid cells limited obesity-associated deterioration of glucose metabolism by promoting sensitivity to insulin in WAT, BAT and the liver.
Enhanced systemic inflammation in Il6ra ∆myel mice fed a HFD Obesity induces a proinflammatory state and the accumulation of macrophages in the adipose tissue 2,3 . To investigate possible inflammatory changes in Il6ra ∆myel fed a HFD, we analyzed gene expression in WAT by quantitative real-time PCR. These analyses revealed higher expression of genes encoding molecules typically linked to the development of resistance to insulin (tumor-necrosis factor (Tnf), IL-1β (Il1b), IL-6 (Il6), IL-12p35 (Il12a) and inducible nitric oxide synthase (Nos2)) in the WAT of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts ( Fig. 2a) . We also observed higher expression of the gene encoding the mineralocorticoid receptor (Nr3c2), which is a marker of M1 macrophages, together with lower expression of the genes encoding the IL-4R α-chain (Il4ra), mannose receptor 1 (Mrc1) and resistin-like-α (Retnla), which are all M2 macrophage-associated genes, in Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts ( Fig. 2a) . Additionally, immunohistochemical analysis of the macrophage markers F4/80 and Mac-2 revealed twofold more crown-like structures in the adipose tissue of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts ( Fig. 2b and Supplementary Fig. 3a) , which indicated a greater abundance of activated macrophages in the Il6ra ∆myel mice. Similarly, the expression of genes encoding proinflammatory molecules and M1-polarization markers was higher in the BAT of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts, while the expression of genes encoding markers of M2 macrophages was significantly lower in the BAT of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts ( Fig. 2c) .
Because Il6ra ∆myel mice fed a HFD displayed substantial hepatic resistance to insulin, we next assessed the expression of genes encoding inflammatory molecules in liver. Consistent with the observed inflammatory changes in WAT and BAT, the livers of Il6ra ∆myel mice fed a HFD had higher expression of Il6, Il12a, Ccl3, Nr3c2 and Nos2 (Fig. 2d) . We did not observe any alteration in the expression of genes encoding proinflammatory cytokines or M1-or M2-polarization markers in any of the tissues analyzed from Il6ra ∆myel mice fed a NCD relative to that in their Il6ra fl/fl counterparts ( Supplementary Fig. 3b-d) . Moreover, Il6 −/− mice fed a HFD, which show a greater propensity to develop diet-induced resistance to insulin 17 , had changes similar to those of their Il6ra ∆myel counterparts in the expression of genes encoding proinflammatory molecules and M2-polarization markers in the WAT and liver ( Supplementary Fig. 4a,b) . We observed no difference between LysM-Cre Tg/wt mice fed a HFD and wild-type mice fed a HFD in their expression of genes encoding inflammatory molecules in the WAT, BAT or liver ( Supplementary Fig. 4c-e ), which excluded the possibility that the observed alterations in Il6ra ∆myel mice might have been dependent on the expression of Cre alone.
To further assess how changes in the expression of genes encoding proinflammatory molecules might promote resistance to insulin, we assessed activation of the kinase Jnk, a critical regulator of obesity-associated resistance to insulin 18 , in the WAT, BAT and liver of Il6ra ∆myel and Il6ra fl/fl mice fed a HFD. Immunoprecipitation of phosphorylated Jnk and a subsequent in vitro kinase assay with a recombinant c-Jun fusion protein revealed six-to tenfold greater activation of Jnk in the WAT, BAT and liver of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts ( Fig. 2e) . These experiments npg A r t i c l e s indicated that IL-6 acted in cells of the myeloid lineage to promote M2 polarization and to limit the expression of genes encoding proinflammatory molecules, activation of Jnk and resistance to insulin in the WAT, BAT and liver of obese mice.
IL-6 signaling promotes IL-4R expression in macrophages
Because Il6ra ∆myel mice fed a HFD exhibited a shift toward the M1 polarization of macrophages in the WAT, BAT and liver, we next investigated the underlying macrophage-autonomous changes that depended on signaling by IL-6. For this, we stimulated control BMDMs (derived from Il6ra fl/fl mice) and Il6ra −/− BMDMs with IL-6 and analyzed gene expression by microarray hybridization. Of 35,518 annotated transcripts, 1,487 were regulated differently in IL-6-stimulated control BMDMs versus Il6ra −/− BMDMs (P ≤ 0.05). Ingenuity pathway analysis of gene-expression patterns revealed differences in the regulation of signaling cascades dependent on the products of the genes Nos2, Il10, Il6 and Pparg (which encodes the transcription factor PPAR-γ), among other pathways (Supplementary Fig. 4f ). The application of the cut-off of a change in expression (upregulation or downregulation) of 1.25-fold yielded 91 transcripts that were regulated, with 31 upregulated and 60 downregulated in Il6ra −/− BMDMs relative to their expression in control BMDMs (Fig. 3a) . Along with Il6ra, one of the transcripts whose expression was diminished the most in the absence of functional signaling by IL-6 was Il4ra (Fig. 3a) . To verify those findings, we did quantitative RT-PCR analysis and observed that stimulation with IL-6 increased Il4ra mRNA expression in control BMDMs ( Fig. 3b and Supplementary Fig. 4g ) and that this response was blunted in Il6ra −/− BMDMs, which exhibited ~95% lower Il6ra mRNA expression than that of control BMDMs (Fig. 3b) ; this indicated efficient disruption of Il6ra. We next analyzed IL-6-stimulated wild-type BMDMs by flow cytometry and observed they had a greater abundance of IL-4Rα than did unstimulated wild-type cells ( Fig. 3c and Supplementary Fig. 4h ).
Because IL-10 can directly induce Il4ra expression in macrophages 19 and IL-6 can stimulate the expression and release of IL-10, we next investigated whether the IL-6-mediated modulatory effects on Il4ra expression were mediated via release of IL-10. Analysis of gene expression showed a robust IL-6-induced increase in Il10 mRNA in control BMDMs (Supplementary Fig. 4i ). While Il6ra −/− BMDMs had a slightly lower abundance of Il10 mRNA than did control BMDMs in the basal state, the IL-6-induced upregulation of Il10 was blunted in Il6ra −/− BMDMs compared with that in control BMDMs (Supplementary Fig. 4i ), which suggested that the observed IL-6-mediated increase in Il4ra expression might have been dependent on autocrine IL-10 signaling. To further pursue that possible mode of action, we next treated wild-type BMDMs with IL-6 in the presence or absence of neutralizing antibody to IL-10, which efficiently blocked IL-10-mediated phosphorylation of STAT3 ( Supplementary  Fig. 4j ). However, IL-6 induced the expression of Il4ra mRNA and IL-4Rα protein to the same extent in BMDMs in which IL-10 was blocked and those treated with control immunoglobulin G (IgG) (Fig. 3d,e ), which indicated that IL-6-dependent upregulation of IL-4Rα expression occurred independently of expression and signaling of IL-10.
We next determined whether the IL-6-mediated expression of IL-4Rα was dependent on STAT3. Knockdown of Stat3 (and, as a positive control, Il6ra) mediated by small interfering RNA (siRNA) diminished expression of Stat3 and Il6ra by ~80% compared with that of BMDMs transfected with control siRNA with a nontargeting sequence (Fig. 3f) . Knockdown of Stat3 or Il6ra in BMDMs potently blunted the IL-6-stimulated induction of Il4ra mRNA by ~70% or ~50%, respectively (Fig. 3g) . The expression of Socs3 (which encodes the inhibitor SOCS3) showed a reduction similar to that of Il4ra after knockdown of Stat3 or Il6ra (Supplementary Fig. 4k) . In summary, we demonstrated that signaling by IL-6 promoted IL-4Rα expression in macrophages in an IL-10-independent manner and that the transcription factor STAT3 was essential in mediating this effect.
STAT3 binds to distinct motifs in the Il4ra promoter To further investigate the role of signaling via IL-6-STAT3 in the regulation of IL-4Rα expression, we looked for STAT3-binding sites in the Il4ra promoter. Analysis with the JASPAR database of transcription A r t i c l e s factor-binding profiles 20 revealed four putative STAT3-binding sites located within 1.3 kilobases upstream of the first exon of the Il4ra promoter, and two putative STAT3binding sites in the Socs3 promoter ( Supplementary Fig. 5a ). To determine which of those sites were necessary for IL-4Rα expression mediated by IL-6-STAT3, we cloned various segments of the Il4ra promoter upstream of Il4ra exon 1 into a firefly luciferase reporter and transfected those constructs into immortalized macrophages 21 (Fig. 4a) .
Only the full-length fragment containing the two distal sites (STAT3_1 and STAT3_2) resulted in robust luciferase expression, and that expression increased substantially after stimulation with IL-6 ( Fig. 4a) . Deletion of those sites almost completely abolished luciferase expression, whereas deletion of the two proximal STAT3-binding sites (STAT3_3 and STAT3_4) did not further diminish luciferase activity (Fig. 4a) ; this indicated that those sites (STAT3_3 and STAT3_4) seemed to be dispensable for IL-6-dependent expression of IL-4Rα.
To determine whether STAT3 regulated Il4ra expression directly, we used an antibody to phosphorylated STAT3 for chromatinimmunoprecipitation (ChIP) analysis. We observed transient but robust occupation of the Socs3 promoter by STAT3 after stimulation with IL-6 in control BMDMs (derived from Il6ra fl/fl mice) but not in Il6ra −/− BMDMs (Supplementary Fig. 5b,c) . Additionally, neither control BMDMs nor Il6ra −/− BMDMs showed enrichment for STAT3 in regions that were not open reading frames, as assessed by ChIP with antibody to phosphorylated STAT3 (negative control region amplified with IGX1A primers) (Supplementary Fig. 5b,c) . Thus, we investigated whether the putative STAT3-binding sites we had identified showed specific enrichment for STAT3 in BMDMs after exposure to IL-6. In line with the luciferase-expression pattern, the two distal STAT3-binding sites (STAT3_1 and STAT3_2) in the Il4ra promoter showed specific enrichment for STAT3 in control BMDMs after stimulation with IL-6, but the two proximal STAT3-binding sites (STAT3_3 and STAT3_4) did not, as assessed by ChIP with antibody to phosphorylated STAT3 ( Fig. 4b and Supplementary Fig. 5c ). We detected no IL-6-induced enrichment for STAT3 at those sites in Il6ra −/− BMDMs ( Fig. 4b and Supplementary Fig. 5c ). Thus, IL-6 induced binding of STAT3 to the Il4ra promoter.
Signaling by IL-6 in myeloid cells augments the IL-4 response
We next investigated if upregulation of IL-4Rα expression rendered macrophages more sensitive to stimulation with IL-4. Immunoblot analysis showed that stimulation with IL-6 potently increased the phosphorylation of STAT3 and expression IL-4Rα in control BMDMs (derived from Il6ra fl/fl mice) but not in Il6ra −/− BMDMs (Fig. 5a) . When we assessed IL-4-stimulated phosphorylation of STAT6, we found that preincubation with IL-6 augmented the response of control BMDMs to IL-4, an effect we did not see in Il6ra −/− BMDM (Fig. 5a) . That suggested that IL-6 not only promoted IL-4Rα expression in macrophages but also augmented the IL-4-mediated phosphorylation of STAT6.
Because IL-4 and STAT6 regulate macrophage polarization by inducing M2-associated genes such as Mrc1 (which encodes the mannose receptor CD206 (MR-1)), Arg1 (which encodes the ureohydrolase arginase), Il10 (which encodes IL-10) and Retnla (which encodes the cytokine Fizz1) 22 , we sought to determine whether IL-6 modulated the expression of M2 macrophage-associated genes in BMDMs. IL-6 induced the expression of Mrc1 and Arg1 in control BMDMs but not in Il6ra −/− BMDMs, whereas the expression of Socs1 (which encodes the signaling inhibitor SOCS1) or Retnla was not modulated by IL-6 ( Supplementary Fig. 6a) . Treatment with IL-4 alone induced similar expression of Socs1, Mrc1, Arg1, Il10 and Retnla in control BMDMs and Il6ra −/− BMDMs (Fig. 5b) , while IL-6 plus IL-4 synergistically enhanced the expression of genes encoding M2 macrophageassociated markers in control BMDMs but not in Il6ra −/− BMDMs (Fig. 5b) . IL-4 and IL-6 acted synergistically to induce expression of the proteins CD206 (MRC1) and arginase, as assessed by flow cytometry of wild-type BMDMs ( Fig. 5c and Supplementary  Fig. 6b) . Moreover, in control BMDMs but not in Il6ra −/− BMDMs, IL-6 acted synergistically with IL-4 to inhibit the expression of Nr3c2 and Tnf, which both encode classic markers of M1 macrophages (Supplementary Fig. 6c ).
We next assessed whether IL-6 acted synergistically with IL-4 to induce the M2 polarization of macrophages in vivo. We treated wild-type mice with IL-6 or IL-4 alone or IL-6 plus IL-4 together and assessed expression of the M2 marker CD206 by flow cytometry in various macrophage compartments. In line with the results obtained for BMDMs in vitro, IL-6 enhanced the IL-4-induced M2 polarization of macrophages from the WAT, BAT, blood and peritoneum in vivo (Fig. 5d,e and Supplementary Fig. 6d,e) .
IL-4 regulates the onset of diet-induced obesity and resistance to insulin 23 . Four weeks of exposure to IL-4 resulted in significantly improved glucose tolerance in Il6ra fl/fl mice fed a HFD but not in their Il6ra ∆myel counterparts ( Fig. 5f and Supplementary Fig. 7a) . 
A r t i c l e s
In addition, treatment with IL-4 diminished the HOMA-IR indices to a greater extent in Il6ra fl/fl mice fed a HFD than in their Il6ra ∆myel counterparts (Supplementary Fig. 7b ). Furthermore, quantitative RT-PCR analysis revealed significantly lower IL-4-induced expression of Mrc1, Retnla and Arg1 in vivo in the WAT, BAT and liver of Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts (Fig. 5g) . Furthermore, in line with the mRNA expression data, we observed less staining of CD206 in the livers of IL-4-treated Il6ra ∆myel mice fed a HFD than in their Il6ra fl/fl counterparts (Fig. 5h) . Thus, myeloid cell-restricted deficiency in IL-6Rα led to resistance to the beneficial effects of IL-4 on glucose homeostasis and sensitivity to insulin in obesity. Furthermore, the activity of IL-6 in macrophages was a necessary prerequisite for IL-4-induced alternative activation of macrophages in vivo.
IL-6 signaling in myeloid cells limits LPS-induced endotoxemia
Next we aimed to determine whether IL-6, in addition to augmenting the IL-4-STAT6 axis, also exhibits anti-inflammatory properties in conditions that promote both classic M1 activation of macrophages and alternative M2 activation of macrophages independently of metabolic inflammation. Therefore, we stimulated control BMDMs (derived from Il6ra fl/fl mice) and Il6ra −/− BMDMs (derived from Il6ra ∆myel mice) with bacterial LPS and assessed the expression of genes encoding typical M1 markers and inflammatory cytokines. LPS alone induced expression of Nos2, Tnf, Il1b and Il12a to the same extent cells of in both genotypes in vitro (Fig. 6a) . However, costimulation with IL-6 blunted the LPS-induced expression of genes encoding inflammatory cytokines by approximately 50% in control BMDMs but not in Il6ra −/− BMDMs (Fig. 6a) . Thus, the transcription of classic LPS-induced cytokines was blunted by IL-6 and that response was not present in BMDMs derived from Il6ra ∆myel mice.
To assess whether IL-6 signaling in macrophages also regulates the inflammatory response to LPS in vivo, we treated Il6ra fl/fl and Il6ra ∆myel mice with a sublethal dose of LPS (1 mg per kg body weight). While treatment with LPS significantly diminished the body weight, food intake and respiratory exchange ratio of mice of both genotypes, those responses were significantly greater in Il6ra ∆myel mice (Fig. 6b-d) .
That was paralleled by a significantly greater abundance of the proinflammatory cytokines TNF, IL-1β and IL-12 in the circulation A r t i c l e s after injection of LPS in Il6ra ∆myel mice than in Il6ra fl/fl mice (Fig. 6e) . Additionally, LPS-treated Il6ra ∆myel mice had a higher concentration of IL-4 in the circulation than did LPS-treated Il6ra fl/fl mice (Fig. 6e) , which indicated possible compensatory upregulation of IL-4 protein in the circulation due to resistance to IL-4 in Il6ra ∆myel mice. Analysis of gene expression in the liver and WAT at 48 h after injection of LPS revealed significantly higher expression of genes encoding inflammatory cytokines in Il6ra ∆myel mice than in Il6ra fl/fl mice, while expression of Il4ra and Retnla was significantly lower in the WAT of Il6ra ∆myel mice (Fig. 6f) . Collectively, these experiments revealed that IL-6 signaling in macrophages limited not only dietinduced inflammation and resistance to insulin but also LPS-induced inflammatory responses (Supplementary Fig. 7c) .
DISCUSSION
In the present study we have, through disruption of the gene encoding IL-6Rα in myeloid cells, identified IL-6 as an additional determinant of macrophage polarization both upon feeding of a HFD and during endotoxemia. Mice with myeloid cell-specific deficiency in Il6ra that were fed a HFD had a greater propensity for disruption of glucose homeostasis and had higher expression of M1 macrophage markers and lower expression of M2 macrophage markers than that of their Il6ra-sufficient counterparts, concomitant with enhanced activation of Jnk in the WAT, BAT and liver. Activation of the expression of genes encoding inflammatory cytokines induces activation of Jnk, which is a well-characterized effector of obesity-associated resistance to insulin 18, 24 . Proinflammatory M1 macrophages are central mediators of obesity-induced inflammation and resistance to insulin 25 , and specific ablation of these cells normalizes sensitivity to insulin in obese, insulin-resistant mice 26 . Conversely, deletion of genes encoding transcription factors such as PPAR-γ that promote the alternative activation of M2 macrophages predisposes lean mice to the development of glucose intolerance and resistance to insulin 27 . Hence, M2 macrophages are critical for metabolic control and, upon the development of obesity, an increased abundance of M1 macrophages leads to the disruption of glucose homeostasis.
Our results have identified IL-6 as a critical instigator of the M2 polarization of macrophages and have assigned it a beneficial role in the prevention of obesity-associated resistance to insulin. That finding may seem unexpected, given the general assumption that IL-6 acts as a proinflammatory cytokine 28 . In fact, blockade of IL-6 signaling has proven a valuable clinical approach for the treatment of rheumatoid arthritis 29 . However, the role of IL-6 in obesity-associated inflammation had remained controversial until now. That stemmed predominantly from clamp experiments indicating that infusion of IL-6 causes resistance to insulin 12 and from the positive correlation between obesity and the amount of IL-6 in the circulation 11 . Nevertheless, studies that have taken alternative approaches have indicated that IL-6 may instead exert beneficial metabolic effects, as IL-6-deficient mice develop late-onset obesity and resistance to insulin 13 . Moreover, HFD-induced inflammation and deterioration of glucose metabolism is enhanced in IL-6-deficient mice 17 , hepatic inactivation of IL-6 signaling promotes resistance to insulin 14 , transgenic overexpression of human IL-6 in mice improves energy and glucose homeostasis 30 and IL-6 enhances insulin secretion via the production of GLP-1, a glucagon-like peptide 31 .
On a cell-autonomous level, we found that IL-6 directly induced expression of IL-4R and therefore primed macrophages for IL-4dependent activation of STAT6. Notably, the IL-4-STAT6 axis is the most potent inducer of the M2 polarization of macrophages, and ablation of the genes encoding IL-4Rα or STAT6 strongly inhibits the alternative activation of macrophages in vitro and in vivo 32, 33 . A published study has demonstrated that during inflammatory conditions, IL-4Rα expression is upregulated specifically in myeloid effector cells 34 . That upregulation is dependent on a soluble protein 34 , which (given our findings here) is probably IL-6. In addition, evidence from the tumor-immunology field indicates that signaling by IL-6 is involved in the polarization of tumorassociated macrophages 35 , which are macrophage subtypes similar to obesity-associated M2 macrophages. However, those studies did not demonstrate the potent IL-4-sensitizing effect of IL-6 that we have documented here. npg Our observations that IL-6 acted not only to prime myeloid cells for signaling by IL-4 during obesity but also to limit LPS-induced endotoxemia indicate that IL-6 generally functions as an antiinflammatory cytokine. That role was assigned to IL-6 more than a decade ago 36 ; however, our results have further extended that conclusion and have demonstrated that such anti-inflammatory properties depend on direct signaling by IL-6 in myeloid cells. In further support of our findings, it has been demonstrated that myeloid cell-specific disruption of SOCS3, the negative regulator of the IL-6-STAT3 axis, skews macrophages toward an M2 phenotype and renders mice more resistant to LPS-induced endotoxemia 37 ; this emphasizes the importance of intact signaling by IL-6 in this context.
Given those observations, we propose that during inflammatory conditions (i.e., in the presence of a greater abundance of free fatty acids and/or bacterial LPS), IL-6 limits the expression of genes encoding inflammatory cytokines and augments the responsiveness of macrophages to IL-4. It thus acts to partially counterbalance the typical shift of macrophage populations toward a proinflammatory M1 phenotype and ultimately diminishes inflammation and the associated resistance to insulin. Together our data have demonstrated a homeostatic role for IL-6 in limiting obesity-associated resistance to insulin and obesity-associated inflammation and have defined a previously unknown mechanism for the control of macrophage polarization. This may set the basis for investigation of the role of IL-6 signaling in macrophages in conditions in which alternative activation is also of critical importance, such as fibrosis, wound healing and carcinogenesis.
METHODS
Methods and any associated references are available in the online version of the paper.
